MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
0.1490
+0.0049 (3.40%)
At close: Nov 16, 2026, 4:00 PM EST
0.1400
-0.0090 (-6.04%)
Pre-market: Nov 17, 2026, 8:07 AM EST

MDxHealth Stock Forecast

MDXH's stock price has decreased by -95.91% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 6 analysts polled by S&P Global, MDxHealth stock has a consensus rating of "Hold" and an average price target of $0.83. The average 1-year stock price forecast is 459.26% higher than the current stock price, while the lowest is $0.50 (+235.57%) and the highest is $1.00 (+571.14%).

Price Target: $0.83 (+459.26%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$0.50$0.83$1.00$1.00
Change+235.57%+459.26%+571.14%+571.14%

Analyst Ratings

The average analyst rating for MDxHealth stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy544411
Buy000000
Hold122255
Sell000000
Strong Sell000000
Total666666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
$0.14 → $1
BuyMaintains$0.14 → $1+571.14%Nov 13, 2026
BTIG
BTIG
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 19, 2026
Lake Street
Lake Street
Hold
Downgrades
$3 → $0.5
HoldDowngrades$3 → $0.5+235.57%Oct 16, 2026
Craig-Hallum
Craig-Hallum
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 16, 2026
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
109.69M
from 107.88M
Increased by 1.69%
Revenue Next Year
121.83M
from 109.69M
Increased by 11.06%
EPS This Year
-0.46
from -0.43
EPS Next Year
-0.38
from -0.46
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
22.24M37.05M70.19M90.05M107.88M109.69M
Revenue Growth
20.47%66.62%89.43%28.29%19.80%1.69%
Gross Profit
10.56M19.22M43.93M55.14M69.63M68.60M
Gross Margin
47.50%51.87%62.58%61.23%64.55%62.53%
Operating Income
-27.88M-38.49M-27.33M-24.72M-14.41M-22.62M
Net Income
-29.00M-44.04M-43.10M-38.07M-33.52M-38.24M
EPS
-----0.43-0.46
Free Cash Flow
-----3.35M-9.40M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High117.4M
Avg109.7M
Low102.7M

Revenue Growth

Revenue Growth202620272028
High
8.9%
Avg
1.7%
Low
-4.8%

EPS Forecast

EPS202620272028
High-0.46
Avg-0.46
Low-0.46

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-